Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancerT. H. van Dijk, Klaas Havenga, A. J. Gelderblom et al.|Annals of Oncology|2013Cited by 147
Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain TumorsPhilippe Aftimos, Dieta Brandsma, Véronique Dièras et al.|Annals of Oncology|2014Cited by 4